161 related articles for article (PubMed ID: 7987859)
1. Circulating concentrations of interleukin-6 in cancer patients and their pathogenic role in tumor-induced hypercalcemia.
Vanderschueren B; Dumon JC; Oleffe V; Heymans C; Gérain J; Body JJ
Cancer Immunol Immunother; 1994 Nov; 39(5):286-90. PubMed ID: 7987859
[TBL] [Abstract][Full Text] [Related]
2. Relationship of plasma bone cytokines with hypercalcemia in cancer patients.
Motellón JL; Jiménez FJ; de Miguel F; Jaras MJ; Díaz A; Hurtado J; Esbrit P
Clin Chim Acta; 2000 Dec; 302(1-2):59-68. PubMed ID: 11074064
[TBL] [Abstract][Full Text] [Related]
3. Serum osteocalcin (BGP) in tumor-associated hypercalcemia.
Body JJ; Cleeren A; Pot M; Borkowski A
J Bone Miner Res; 1986 Dec; 1(6):523-7. PubMed ID: 3509743
[TBL] [Abstract][Full Text] [Related]
4. Circulating PTHrP concentrations in tumor-induced hypercalcemia: influence on the response to bisphosphonate and changes after therapy.
Body JJ; Dumon JC; Thirion M; Cleeren A
J Bone Miner Res; 1993 Jun; 8(6):701-6. PubMed ID: 8328312
[TBL] [Abstract][Full Text] [Related]
5. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
6. Urinary pyridinium cross-links as markers of bone resorption in tumor-associated hypercalcemia.
Body JJ; Delmas PD
J Clin Endocrinol Metab; 1992 Mar; 74(3):471-5. PubMed ID: 1740478
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer.
Grill V; Ho P; Body JJ; Johanson N; Lee SC; Kukreja SC; Moseley JM; Martin TJ
J Clin Endocrinol Metab; 1991 Dec; 73(6):1309-15. PubMed ID: 1955513
[TBL] [Abstract][Full Text] [Related]
8. Serum bone GLA-protein in hypercalcemia of primary hyperparathyroidism and malignancy.
Di Virgilio R; De Lazzari M; Da Rin G; Legovini P; Foscolo G; Roiter I; Conte N
Tumori; 1990 Feb; 76(1):32-4. PubMed ID: 2321272
[TBL] [Abstract][Full Text] [Related]
9. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of calcium reabsorption observed in advanced breast cancer patients with hypercalcemia and multiple bone metastases.
Kimura S; Adchi I; Yamaguchi K; Suzuki M; Shimada A; Sato Y; Nagaoka K; Abe K
Jpn J Cancer Res; 1985 Apr; 76(4):308-14. PubMed ID: 2989061
[TBL] [Abstract][Full Text] [Related]
11. Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma.
Seymour JF; Gagel RF; Hagemeister FB; Dimopoulos MA; Cabanillas F
Ann Intern Med; 1994 Nov; 121(9):633-40. PubMed ID: 7944070
[TBL] [Abstract][Full Text] [Related]
12. Hypercalcemia in a patient with B-cell acute lymphoblastic leukemia: a role of proinflammatory cytokine.
Fukasawa H; Kato A; Fujigaki Y; Yonemura K; Furuya R; Hishida A
Am J Med Sci; 2001 Aug; 322(2):109-12. PubMed ID: 11523624
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone and parathyroid hormone related protein assays in the investigation of hypercalcemic patients in hospital in a Chinese population.
Lee JK; Chuang MJ; Lu CC; Hao LJ; Yang CY; Han TM; Lam HC
J Endocrinol Invest; 1997; 20(7):404-9. PubMed ID: 9309539
[TBL] [Abstract][Full Text] [Related]
14. Elevation of circulating plasma cytokines in cancer patients with high plasma parathyroid hormone-related protein levels.
Takahashi S; Hakuta M; Aiba K; Ito Y; Horikoshi N; Miura M; Hatake K; Ogata E
Endocr Relat Cancer; 2003 Sep; 10(3):403-7. PubMed ID: 14503917
[TBL] [Abstract][Full Text] [Related]
15. Hypercalcemia in dogs with lymphosarcoma. Biochemical, ultrastructural, and histomorphometric investigations.
Meuten DJ; Kociba GJ; Capen CC; Chew DJ; Segre GV; Levine L; Tashjian AH; Voelkel EF; Nagode LA
Lab Invest; 1983 Nov; 49(5):553-62. PubMed ID: 6314038
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone-related protein, parathyroid hormone, and vitamin D in hypercalcemia of malignancy.
Motellón JL; Javort Jiménez F; de Miguel F; Jaras MJ; Díaz A; Hurtado J; Esbrit P
Clin Chim Acta; 2000 Jan; 290(2):189-97. PubMed ID: 10660809
[TBL] [Abstract][Full Text] [Related]
17. Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy.
Akatsu T; Murakami T; Ono K; Nishikawa M; Tsuda E; Mochizuki SI; Fujise N; Higashio K; Motoyoshi K; Yamamoto M; Nagata N
Bone; 1998 Dec; 23(6):495-8. PubMed ID: 9855457
[TBL] [Abstract][Full Text] [Related]
18. Decreased efficacy of bisphosphonates for recurrences of tumor-induced hypercalcemia.
Body JJ; Louviaux I; Dumon JC
Support Care Cancer; 2000 Sep; 8(5):398-404. PubMed ID: 10975689
[TBL] [Abstract][Full Text] [Related]
19. Plasma prostaglandin E in patients with cancer with and without hypercalcemia.
Robertson RP; Baylink DJ; Metz SA; Cummings KB
J Clin Endocrinol Metab; 1976 Dec; 43(6):1330-5. PubMed ID: 1002818
[TBL] [Abstract][Full Text] [Related]
20. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
Pierreux J; Bravenboer B
Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]